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Abstract 
Background : To assess the reduced glutathione 
(GSH) levels  as marker of oxidative stress in 
patients of diabetes mellitus  
Methods:  In this cross sectional study 40 subjects 
were divided  into two groups. One group was 
designated as control while the other was diabetic. 
Glycemic status was measured to confirm their 
normal and diabetic states respectively. Plasma 
reduced GSH level was measured by using standard 
ELISA kits.  
Results: Level of reduced GSH was decreased in 
the diabetic  group (18.4 ± 1.35) as compared to the 
control group(27.5 ± 1.38).  
Conclusion: Levels of reduced GSH were 
significantly decreased in patients of diabetes 
mellitus as compared to normal healthy controls.   
Key Words: Diabetes mellitus, oxidative stress, 
reduced glutathione marker. 
 
Introduction 
     Oxidative stress is an imbalance between the 
production of reactive oxygen and ability of the 
biological system to detoxify the reactive intermediates 
or to repair the resulting damage. The destructive 
aspect of oxidative stress is the production of reactive 
oxygen species (ROS), which include free radicals and 
peroxides, that  can damage nucleic acids, proteins 
and cell membranes.1 Oxidative stress occurs when 
ROS production exceeds than their removal by the 
cellular defense mechanism. In humans, oxidative 
stress is involved in many diseases, such as diabetes 
mellitus (DM), atherosclerosis, myocardial infarction 
(MI), heart failure, Parkinson's disease, chronic fatigue 
syndrome, Alzheimer's disease and  fragile X 
syndrome.2,3 
     DM is a continuous source of oxidative stress to the 
body and there is increased generation of ROS. These 
ROS have a very short half-life and cannot remain as 
such and react rapidly with DNA, protein, and lipids, 
thereby leading to oxidative damage. Oxidative stress 
occurs in diabetic patients due to increase in the 
steady-state levels of ROS, which is a result of 
decreased anti-oxidant defense mechanism and 
increased free radical generation. These ROS are 
involved in the development of diabetic complications 
like blindness, renal failure, neuropathy and 
myocardial infarction.2,4 
     Hyperglycemia is the initiating cause of oxidative 
stress in diabetics. It causes repeated acute changes in 
cellular glucose metabolism and long-term 
accumulation of glycosylated biomolecules and 
advanced glycation end products (AGEs). In the 
presence of uncontrolled hyperglycemia, the increased 
formation of AGEs and lipid peroxidation products 
exacerbate intracellular oxidative stress, disruption in 
cellular signaling and homeostasis followed by 
inflammation and tissue injury such as endothelium 
dysfunction, arterial stiffening and microvascular 
complications. 5 
 
     In diabetics, there are also other multiple pathways 
enhancing ROS production, which includes; protein 
kinase C-dependent activation of NADPH oxidase, 
enhanced glucose auto-oxidation, uncoupled 
endothelial nitric oxide synthase activity, increased 
mitochondrial superoxide production and stimulation 
of eicosanoid metabolism.4 
 
Patients and Methods  
    This cross sectional study was conducted at 
Department of Biochemistry & Molecular Biology, 
Army Medical College, Rawalpindi in collaboration 
with Combined Military Hospital (CMH), Rawalpindi 
and Centre for Research in Experimental and Applied 
Medicine (CREAM), Army Medical College, 
Rawalpindi for blood sampling and biochemical 
assays respectively. Total duration of study was 01 
year and was performed on 40 adult volunteer human 
subjects of both sexes, with a body mass index 
between 19 – 40 kg/m2. They were divided into two 
groups containing 20 subjects each. One group was 
designated as control (healthy) group while the other 
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was diseased (diabetic) group.   Control group (Group 
1)comprised of 20 normal healthy humans having 
normal fasting blood glucose levels (between 70 – 100 
mg/dl). Pregnant women, person suffering from any 
chronic illness or disease or taking any sort of 
medication / supplements were excluded. Diabetic 
Group (Group II) had  20 patients suffering from type 
2 dabetes mellitus having fasting blood glucose in a 
range of 126 – 400 mg/dl, despite taking their usual 
anti-diabetic medication. Patients on insulin therapy, 
pregnant women, persons suffering from any other 
chronic illness or taking any medication other than 
that of diabetes were excluded.Patients of both sexes 
with known type – II diabetic history and fulfilling all 
the inclusion criteria were screened by determining 
their fasting blood glucose by a glucometer. Similarly, 
healthy individuals were screened by determining 
their fasting blood glucose before selection for the 
study. Reduced glutathione (GSH) was measured by 
enzyme linked immuno-sorbent assay (ELISA) 
method.A p value of ≤ 0.05 and ≤0.01 was considered 
significant and highly significant respectively.  
 
Results 
     The mean reduced Glutathione in control group 
was 27. 5 ng/ml, while in diabetic group it was 18.4 
ng/ml (Table 1). There was a highly significant 
difference (p < 0.001) between the control and diabetic 
groups (Table 2).  
Table 1:Oxidative stress marker (GSH) of control & 
diabetic group. 
Study 
Group 
Parameter 
Sample 
Size 
Mean 
Standard 
error of 
mean 
(SEM) 
Control 
Group 
Reduced 
Glutathione 
(GSH) 
(ng/ml) 
20 27.5 1.383 
Diabetic 
Group 
20 18.4 1.346 
 
Table 2: Students paired t-test of oxidative stress 
between control and diabetic group 
 
Study 
Group 
Parameter Mean ± SEM p-value 
Control 
Group 
Reduced 
Glutathione 
(GSH) 
(ng/ml) 
27.5 ± 1.383 
0.000 * 
Diabetic 
Group 
18.4 ± 1.346 
* p < 0.001 Highly significant 
 
Discussion 
     Glutathione, an antioxidant, helps protect cells from 
reactive oxygen species (ROS) such as free radicals and 
peroxides. In healthy cells and tissues, more than 90% 
of the total glutathione pool is in the reduced form 
(GSH) and less than 10% exists in the disulfide form 
(GSSG). An increased GSSG-to-GSH ratio is 
considered indicative of oxidative stress.In our study, 
blood level of reduced GSH was in the range of 14 – 38 
ng/ml with a mean value of 27.5 ± 1.383 for the control 
group compared to 9 – 31 ng/ml with a mean value of 
18.4 ± 1.346 for the diabetic group. GSH was 
significantly reduced in diabetics as compared to 
normal healthy persons (p < 0.001). Studies found an 
association between non enzymatic glycation and 
oxidative stress in the pathogenesis of diabetic 
complications.6,7 Enzymatic glycation is found to be  
linked to both glucose auto oxidation and proteins 
glycation processes, which in turn proceed to the 
formation of free radicals. This coupled with long term 
high glucose levels results in the major complications 
of diabetes. Studies carried out by Sasaki, S. et al and 
Brownlee, M. et al also support these facts.8, 9  
Tagliabue, M. et al in their study  presented 
that levels of GSH are significantly decreased in type 2 
diabetics.10 In conjugation to this, Soliman, GZ. and 
Ozdemir, G. carried out experiments to evaluate the 
role of GSH levels in the pathophysiology of type 2 
diabetes . They emphasized on the link between 
exaggerated oxidative stress and hyperglycemia 
leading to clinical complications of type 2 
diabetics.11,12Sekhar, et al concluded from their studies 
in uncontrolled diabetes that glutathione synthesis is 
decreased in these patients.13  Decreased levels of  
reduced glutathione levels aggravate diabetic 
complications.14,15  
 
Conclusion 
Levels of reduced GSH are significantly decreased in 
diabetics as compared to normal healthy persons.   
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